Comparison of 3 versus 6 cycles CMF in node positive breast cancer patients based on 10 years follow-up

被引：0
|
作者：
Sauerbrei, W
Bastert, G
Bojar, H
Schmoor, C
Schumacher, M
机构：
[1] Univ Freiburg, Inst Med Biometry & Med Informat, D-7800 Freiburg, Germany
[2] Univ Heidelberg, Dept Gynecol, D-6900 Heidelberg, Germany
[3] Univ Dusseldorf, Dept Chem Oncol, D-4000 Dusseldorf, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1998年 / 34卷
关键词：
D O I：
10.1016/S0959-8049(98)80156-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
165
引用
收藏
页码：S41 / S41
页数：1
相关论文
共 50 条
  • [1] Effect of radiotherapy in addition to 6 cycles CMF in node positive breast cancer patients
    Schmoor, C
    Bastert, G
    Bojar, H
    Sauerbrei, W
    Schumacher, M
    [J]. EUROPEAN JOURNAL OF CANCER, 1998, 34 : S59 - S59
  • [2] A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up
    Walshe, Janice M.
    Berman, Arlene W.
    Vatas, Ujala
    Steinberg, Seth M.
    Anderson, William F.
    Lippman, Marc E.
    Swain, Sandra M.
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2007, 103 (02) : 177 - 183
  • [3] A prospective study of adjuvant CMF in males with node positive breast cancer: 20-year follow-up
    Janice M. Walshe
    Arlene W. Berman
    Ujala Vatas
    Seth M. Steinberg
    William F. Anderson
    Marc E. Lippman
    Sandra M. Swain
    [J]. Breast Cancer Research and Treatment, 2007, 103 : 177 - 183
  • [4] Randomized trial on the effect of radiotherapy in addition to 6 cycles CMF in node-positive breast-cancer patients
    Schmoor, C
    Bastert, G
    Dunst, J
    Bojar, H
    Christmann, D
    Unbehaun, V
    Tümmers, G
    Bauer, W
    Sauerbrei, W
    Schumacher, M
    [J]. INTERNATIONAL JOURNAL OF CANCER, 2000, 86 (03) : 408 - 415
  • [5] Positive molecular sentinel node (pNmol plus ) in breast cancer patients. A follow-up study up to 7 years.
    Benitez Segura, A.
    Bajen Lazaro, M.
    Rodriguez-Bel, L.
    Mora, J.
    Ricart, Y.
    Roca, M.
    Varela, M.
    Climent, J.
    Urruticoechea, A.
    Pla, M.
    Masuet, C.
    Martin-Comin, J.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2009, 36 : S306 - S306
  • [6] Randomized 2 x 2 trial evaluating hormonal treatment and the duration of chemotherapy in node-positive breast cancer patients: An update based on 10 years' follow-up
    Sauerbrei, W
    Bastert, G
    Bojar, H
    Beyerle, C
    Neumann, RLA
    Schmoor, C
    Schumacher, M
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (01) : 94 - 101
  • [7] Adjuvant chemotherapy with CEF versus CMF for node-positive breast cancer
    Atkins, CD
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (12) : 3916 - 3917
  • [8] CYCLOPHOSPHAMIDE, METHOTREXATE, AND FLUOROURACIL IN NODE-POSITIVE BREAST-CANCER - THE RESULTS OF 20 YEARS OF FOLLOW-UP
    BONADONNA, G
    VALAGUSSA, P
    MOLITERNI, A
    ZAMBETTI, M
    BRAMBILLA, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (14): : 901 - 906
  • [9] Clinical node negative breast cancer patients undergoing breast conserving therapy: follow-up versus sentinel lymph node biopsy
    van Roozendaal, L. M.
    Smidt, M. L.
    de Wilt, H. H. W.
    van Dalen, T.
    Strobbe, L. J. A.
    van der Hage, J.
    Tjan-Heijnen, V. C. G.
    Linn, S. C.
    Serroyen, J. L.
    [J]. CANCER RESEARCH, 2012, 72
  • [10] DNA CYTOPHOTOMETRIC ANALYSIS OF BREAST-CANCER - FOLLOW-UP FOR 10 YEARS
    GUZMAN, J
    RUCKMANN, A
    GLASER, A
    WITTEKIND, C
    SCHONFELD, B
    KIEFER, G
    [J]. ANALYTICAL AND QUANTITATIVE CYTOLOGY AND HISTOLOGY, 1992, 14 (06): : 427 - 432
12345